© 2022 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
June 12, 2017
Jan A. Burger, MD, PhD and Javier Pinilla-Ibarz, MD, PhD shed light on the field of CLL and the transformative role of ibrutinib.
An overview of emerging targeted therapies and immunotherapies in chronic lymphocytic leukemia.
June 09, 2017
An overview of the factors affecting prognosis and treatment in chronic lymphocytic leukemia.
Current treatment strategies for chronic lymphocytic leukemia (CLL).
June 08, 2017
CLL is a malignancy characterized by the clonal proliferation and accumulation of small, mature-appearing CD5-positive B lymphocytes in the blood, bone marrow, and secondary lymphoid tissues.